Status:

UNKNOWN

Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV

Lead Sponsor:

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborating Sponsors:

Centers for Disease Control and Prevention

Government of Bangladesh

Conditions:

Polio

Eligibility:

All Genders

42-48 years

Phase:

PHASE4

Brief Summary

The goal of this clinical trial is to explore two strategies to enhance nOPV2 immunogenicity in the field and overcome potential interference of bOPV: 1. Addition of IPV after one or several doses of...

Detailed Description

The study will assess whether adding IPV at the end of a 3-dose series of co-administered nOPV2+bOPV achieves at least a 95% seroconversion to all serotypes and whether adding IPV following two doses ...

Eligibility Criteria

Inclusion

  • Healthy infants 6 weeks of age
  • Parents that consent for participation in the full length of the study.
  • Parents that can understand and comply with planned study procedures.

Exclusion

  • Parents and infants are unable to participate in the full length of the study
  • A diagnosis or suspicion of immunodeficiency disorder either in the infant or in an immediate family member.
  • A diagnosis or suspicion of bleeding disorder
  • Acute diarrhoea, infection, or illness at the time of enrolment
  • Acute vomiting and intolerance to liquids within 24 hours before the enrolment visit
  • Evidence of a chronic medical condition
  • Receipt of any polio vaccine (OPV or IPV) before enrolment
  • Known allergy/sensitivity or reaction to polio vaccine, or its contents.
  • Infants from multiple births.
  • Infants from premature births (\<37 weeks of gestation).

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

880 Patients enrolled

Trial Details

Trial ID

NCT06114810

Start Date

November 1 2023

End Date

September 1 2024

Last Update

November 7 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV | DecenTrialz